Anesthetic Gas Safety, Neuropathology, and Consciousness Research
This community investigates the neurological effects of anesthetic gases, particularly nitrous oxide and xenon, and studies the pathophysiology of brain injury following cardiac arrest and hypoxic-ischemic events. It also encompasses clinical trials and mechanistic research into the neural basis of consciousness and the therapeutic potential of psychedelic compounds.
The work centers on the safety profiles of nitrous oxide and xenon in clinical anesthesia, with a strong focus on their impact on neurodevelopment in preterm infants and adults. A significant portion of the research addresses the mechanisms and management of postoperative delirium, traumatic brain injury, and hypoxic-ischemic encephalopathy. The community also explores the neurophysiological underpinnings of consciousness, including EEG patterns and receptor signaling pathways associated with psychedelic-assisted therapies. Methodologies include randomized controlled trials, systematic meta-analyses, and animal models of brain injury.
The largest share of the community's output is found in xenon research, accounting for 3.2% of all xenon research tracked, and 1,248 papers here. Oxygen research contributes the highest paper count within this group, with 3,957 papers, though this represents only 0.7% of all oxygen research.
The community comprises 14,704 papers, publishing most frequently in Anesthesiology, the British Journal of Anaesthesia, and Anesthesia & Analgesia. Recent work includes guidelines for post-resuscitation care, investigations into aperiodic neural activity, and studies on the cardiovascular effects of intra-abdominal hypertension.